User

Relationship between Anxiety Score and Erythrocyte Sedimentation Rate (ESR) in Hemodialysis Patient

Rohmaningtyas Hidayah Setyaningrum, Debree Septiawan, Jhonny Prambudi Batong

Abstract

Background: Anxiety in hemodialysis pati­ents often impaired quality of life. Complex interaction between Chronic Kidney Disease (CKD) and anxiety are dynamic and multifac­torial, including socio-economic, lifestyle and biological factors. Biological factors are close­ly related to anxiety in CKD including the im­mune system, inflammatory pathways of dis­orders of Hypothalamic-Pituitary-Adrenal Axis (HPA). Erythrocyte sedimentation rate (ESR) is one of the non-specific inflammatory marker that show the degree of inflammatory reaction, Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) also found as an easy and inexpensive mea­sureable marker to show the degree of inflam­mation. This study aimed to examine rela­ti­onship between anxiety and hematology in­flammation markers in hemodialysis patient.

Subjects and Method: This was an obser­vational study with a cross-sectional design. The study was conducted at Dr. Moewardi general hospital, Surakarta, Central Java. A sample of 30 hemodialysis patients was selec­ted for this study. The dependent variables were ESR, NLR, and PLR. The independent variable was anxiety. Anxiety was measured by Taylor Manifest Anxiety Scale (TMAS). Data on ESR, NLR, and PLR, were measured using an assessment from RAND Corpora­tion. The data were analyzed by a multiple linear regression.

Results:  Anxiety increased NLR and it was marginally significant (b= 0.37; 95% CI= -0.01 to 0.22; p= 0.080). Anxiety decreased ESR and it was statistically significant (b= -0.57; 95% CI= -0.02 to 0.01; p<0.001). An­xiety decreased PLR (b= -0.16; 95% CI= -0.02 to 0.01; p= 0.440) and duration of hemo­dia­lysis (b= -0.27; 95% CI= -0.03 to 0.01; p= 0.167), but they were statistically non-signi­ficant.

Conclusion: Anxiety increases NLR. Anxi­ety decreases ESR, PLR, and duration of hemo­dialysis.

Keywords: chronic kidney disease, hemo­dialysis, hematology markers, inflammation

Correspondence: Rohmaningtyas Hidayah Setyaningrum. De­partment of Psychiatry, Faculty of Medicine, Universitas Sebelas Maret/ Dr. Moewardi General Hospital, Surakarta, Central Java. Email: astitdr@gmail.com

Indonesian Journal of Medicine (2020), 05(02): 109-115
https://doi.org/10.¬26911/theijmed.2020.05.02.03

Full Text:

PDF

References

Aggarwal HK, Jain D, Dabas G, Yadav RK (2017). Prevalence of depression, anxiety and insomnia in chronic kidney disease patients and their corelation with the demographic variables. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 38(2):35-44. https://doi.org/10.1515/prilozi-2017-0020


Alcocer Gómez E, Castejón Vega B, Cordero MD (2017). Stress Induced NLRP3 Inflammasome in Human Diseases. Adv Protein Chem Struc Biol. 108: 127-162. https://doi.org/10.1016/bs.apcsb.2017.02.002


Arismawati (2016). Hubungan antara pemaafan (forgiveness) dengan kecemasan (anxiety) pada remaja yang orangtuanya bercerai. Available: http://repository.upi.edu/25239/.


Bautovich A, Katz I, Smith M, Loo CK, Harvey SB (2014). Depression and chronic kidney disease: A review for clinicians. Australian New Zealand J Psychiatry. 48(6): 530-541. https://doi.org/10.1177/0004867414528589


Bilen Y, Cankaya E, Keles M, Gulcan E, Uyanik A, Turkeli M, Albayrak B, Yildirim R (2014). Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients?. Ren Fail. 36(1): 69-72. https://doi.org/10.3109/0886022X.2013.832310


Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, Yale SH (2016). Erythrocyte sedimentation rate and Creactive protein measurements and their relevance in clinical medicine. Wilconsin Med J. 115(6): 17-21. https://www.ncbi.nlm.nih.gov/pubmed/29094869


Harrison M (2015). Erythrocyte sedimentation rate and Creactive protein. Australian Prescriber. 38(3): 93-94. Doi: 10.18773/austprescr.2015.034


Iwagami M, Tomlinson LA, Mansfield KE, McDonald HI, Smeeth L, Nitsch D (2017). Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf. 26(7): 792-801. https://doi.org/10.1002/pds.4212


Lopresti AL, Maker GL, Hood SD, Drummond PD (2014). A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers. Prog Neuropsychopharmacol Biol Psychiatry. 48: 102-11. https://doi.org/10.1016/j.pnpbp.2013.09.017


Gay LR, Diehl PL (1992). Research methods for business and management. Pennsylvania State University: Macmillan Publishing Company.


Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T (2016). Inflammation in fear and anxietybased disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 42(1): 254-270. https://doi.org/10.1038/npp.2016.146


Melmed S, Jameson LJ (2015). Anterior pituitary: Physiology of pituitary hormones," in Harrison's Principles of Internal Medicine, Nineteenth ed., New York: McGraw Hill Education.


Miller AH, Raison CL (2016). The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nature Reviews Immunology. 16(1):22-34. https://doi.org/10.1038/nri.2015.5


Nicolau J, Simo R, Sanchís P, Ayala L, Fortuny R, Masmiquel L (2017). Effects of depressive symptoms on clinical outcomes, inflammatory markers and quality of life after a significant weight loss in a bariatric surgery sample. Nutrición Hospitalaria. 34(1): 81-87. https://doi.org/10.20960/nh.979


Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, Ozbicer A, Demirtas L, Turk S, Tonbul HZ (2013). Platelet tolymphocyte ratio better predicts inflammation than neutrophil to lymphocyte ratio in end stage renal disease patients. Hemodialysis Internationa. 17(3): 391-396. https://doi.org/10.1111/hdi.12040


Valsaraj BP, Bhat SM, Latha KS (2016). Cognitive behaviour therapy for anxiety and depression among people undergoing haemodialysis: a randomized control trial. Journal of Clinical and Diagnostic Research. 10(8): VC06–VC10. https://dx.doi.org/10.7860%2FJCDR%2F2016%2F18959.8383.


Vaziri ND, Pahl MV, Crum A, Norris K (2012). Effect of uremia on structure and function immune system. Journal Renal Nutrition. 22(1): 149-156. https://doi.org/10.1053/j.jrn.2011.10.020


Zahed NS, Sharifi M, Karimi M, Nikbakht H (2017). Impact of sertraline on serum concentration of CRP in Hemodialysis patients with depression. Journal of Renal Injury Prevention. 6(1):65-69. https://dx.doi.org/10.15171%2Fjrip.2017.12

Refbacks

  • There are currently no refbacks.